Eurofarma, a Brazilian-based multinational pharmaceutical corporation operating in 22 countries, launched a new facial expression recognition experimental tool powered by artificial intelligence that enables patients with Parkinson’s disease to control their social media engagement using facial expressions.
Hyperacusis, a heightened sensitivity to sounds, can be a profoundly distressing challenge for those living with autism. This condition can lead to fear, anxiety, and social isolation.
Samsung developed a unique tool that combines specialized earbud hardware with AI-driven software to modulate noise selectively. It provides a means for people living with autism to manage sensory overload and enhance their quality of life and overall well-being.
The rise of smartphones, wearables, and health apps has fundamentally changed how people interact with their health.
Patients now have unprecedented access to health information, allowing them to monitor their well-being, track symptoms, research potential treatments, and even find digital tools to help with their condition.
The pharmaceutical industry has historically focused on developing and marketing products to treat specific diseases or conditions. This approach often viewed patients as passive treatment recipients with limited involvement in their healthcare journey.
